Cited by 21Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentProtein Kinase Regulation and GTPase Signaling

Differential Cell Susceptibilities to Kras in the Setting of Obstructive Chronic Pancreatitis

Open access
Shi, Chanjuan, Pan, Fong Cheng, Kim, Jessica N., Washington, M. Kay, Padmanabhan, Chandrasekhar, Meyer, Christian T., Kopp, Janel L., Sander, Maike +4 more·2019·Cellular and Molecular Gastroenterology and Hepatology

Abstract

BACKGROUND & AIMS: Activating mutation of the KRAS gene is common in some cancers, such as pancreatic cancer, but rare in other cancers. Chronic pancreatitis is a predisposing condition for pancreatic ductal adenocarcinoma (PDAC), but how it synergizes with KRAS mutation is not known. METHODS: We used a mouse model to express an activating mutation of Kras in conjunction with obstruction of the main pancreatic duct to recapitulate a common etiology of human chronic pancreatitis. Because the cell of origin of PDAC is not clear, Kras mutation was introduced into either duct cells or acinar cells. RESULTS: expression in both cell types was protective against damage-associated cell death, chronic pancreatitis induced p53, p21, and growth arrest only in acinar-derived cells. Mutant duct cells did not elevate p53 or p21 expression and exhibited increased proliferation driving the appearance of PDAC over time. CONCLUSIONS: -initiated tumorigenesis is whether they undergo a p53-mediated damage response. In summary, we have uncovered a mechanism by which inflammation and intrinsic cellular programming synergize for the development of PDAC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcmgh.2019.07.001

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Induction of pancreatic damage by pancreatic ductal ligation is sufficient to promote KRAS-mediated ductal-lineage tumorigenesis.

    “the induction of pancreatic damage by pancreatic ductal ligation is sufficient to promote KRAS-mediated ductal-lineage tumorigenesis128.”

    From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [128]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shi, C., Pan, F. C., Kim, J. N., Washington, M. K., Padmanabhan, C., Meyer, C. T., Kopp, J. L., Sander, M., Gannon, M., Beauchamp, R. D., Wright, C. V., & Means, A. L.
Affiliations
  • Vanderbilt University Medical Center (US)
  • University of California San Diego (US)
  • VA Tennessee Valley Healthcare System (US)
Corresponding author
Means, Anna L.
Venue
Cellular and Molecular Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2019
Volume
8
Issue
4
Pages
579-594
ISSN
2352-345X (ISSN-L)
OpenAlex
W2958380790
Cited by
21
References
43
Citations by year
2026: 1 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 6 · 2020: 4 · 2019: 1
FWCI
1.25
Type
journal article
Language
en
Open access
Locations
  • Cellular and Molecular Gastroenterology and Hepatology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
Funders
  • NIH (R21CA123061, P50CA095103, P30DK058404, R01DK105689, F32CA136124, P30CA068485)
  • JDRF (U01DK072473, R01DK078803, R21CA194839)
  • VA (1I01BX003744-01)
  • Vanderbilt-Ingram Cancer Center (P30CA068485)
  • Vanderbilt Digestive Diseases Research Center (P30DK08404)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
KRAS mutation, chronic pancreatitis, pancreatic ductal adenocarcinoma, pancreatic duct obstruction, acinar cells, duct cells, p53, p21, cell of origin, inflammation-driven tumorigenesis, mouse model
MeSH terms
Animals, Cell Transformation, Neoplastic, Disease Models, Animal, Metaplasia, Mutation, Pancreatic Neoplasms, Precancerous Conditions, Genes, ras, Signal Transduction, Proto-Oncogene Proteins p21(ras), Carcinoma, Pancreatic Ductal, Pancreatitis, Chronic, Mice, Acinar Cells, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review